Enrollment Strategies for Metabolic Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to boost participation in a wellness program for weight management and diabetes prevention. It compares two approaches: one where eligible individuals receive an invitation to join, and another where they are automatically enrolled with the option to opt out. The trial seeks employees or their spouses/domestic partners with metabolic syndrome, which may include a large waistline, high blood pressure, or high blood sugar. Participants should have experience with these health issues in their daily lives. As an unphased trial, this study provides a unique opportunity to contribute to innovative wellness strategies that could benefit many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.
What prior data suggests that this outreach strategy is safe?
Research shows that wellness programs like the one in this study are generally safe for participants. These programs involve health coaching and lifestyle changes, which are non-invasive and carry minimal risk. Although specific safety data for this trial is not yet available, similar programs typically report few, if any, negative effects. This trial is in the "Not Applicable" phase, indicating it doesn't involve testing a new drug or device, which usually means lower risk. The study focuses more on how people join the program rather than the program's safety itself.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to engage people with metabolic syndrome in wellness programs. Traditional approaches often rely on individuals opting in, which can limit participation. This trial compares the usual opt-in method with an opt-out approach, where eligible individuals are automatically enrolled and simply invited to start. This could significantly increase participation and, subsequently, the effectiveness of wellness interventions. By testing these two methods, researchers hope to discover more efficient ways to boost engagement and improve health outcomes for those with metabolic syndrome.
What evidence suggests that this trial's outreach strategies could be effective for increasing engagement in wellness programs?
Research has shown that wellness programs like Pack Health can aid in weight control and diabetes prevention. Studies have found that increased participation in these programs often leads to improved health outcomes. In this trial, participants will be divided into two groups: one using an opt-out approach, where individuals are automatically enrolled unless they choose not to participate, and another using the usual opt-in method, where individuals are invited to join. Early findings suggest that the opt-out method could result in higher participation compared to the opt-in method. Greater participation typically leads to better results in managing health issues like metabolic syndrome.12346
Who Is on the Research Team?
Joseph Doyle, PhD
Principal Investigator
MIT Sloan School of Management
Are You a Good Fit for This Trial?
This trial is for employees and their spouses or domestic partners who are eligible to participate in Pack Health, a wellness program aimed at weight management and diabetes prevention. The study will test if automatically enrolling people with the option to opt out increases engagement compared to just inviting them.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are randomly assigned to either the opt-in or opt-out outreach group to evaluate engagement with the wellness program
Follow-up
Participants are monitored for engagement levels and health outcomes, including risk assessments and healthcare claims
Extended Follow-up
Additional health outcomes such as HbA1c and weight are assessed in the following year's Annual Risk Assessment
What Are the Treatments Tested in This Trial?
Interventions
- Wellness Program Outreach
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts Institute of Technology
Lead Sponsor
University of Illinois at Urbana-Champaign
Collaborator
Quest Diagnostics-Nichols Insitute
Industry Sponsor